Lates News

In its second-quarter report released on Tuesday, AstraZeneca emphasized that the US market is crucial for achieving its goal of reaching $80 billion in revenue by 2030. The company's CEO, Soriot, pointed out, "We are a global enterprise, but the United States has always been our strategic foundation."